D. P. Hurkmans
0000-0002-8750-5188
5 papers found
Refreshing results…
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma
A serum protein classifier identifying patients with advanced non-small cell lung cancer who derive clinical benefit from treatment with immune checkpoint inhibitors
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
Missing publications? Search for publications with a matching author name.